News
The company will maintain its patent right for the technology.
Docquity will use its fresh funds to further expand into East Asia and the Middle East.
According to an SEC filing, the cuts will primarily affect its technology-focused and marketing groups.
Receiving opioid use disorder-related telehealth services during the COVID-19 pandemic was associated with lower odds of overdose and better retention using medications like buprenorphine, according to a study published in JAMA Psychiatry.
Also, Lunit has received Taiwan's approval for its AI mammography solution.
The company also announced Washington-based MultiCare Health System will be the first to license its tools for Indigo Health, the health system's hybrid urgent and primary care service.
Augment Health cofounders Jared Meyers and Stephen Kalinsky describe their device that aims to improve the quality of life for people with bladder-control issues stemming from brain, spinal cord or nerve problems.
The AI model still has a modest prediction accuracy and is slated for a wider clinical trial soon.
It provides a range of information and resources to support people with down syndrome.
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.